1. Home
  2. ASPI vs KMDA Comparison

ASPI vs KMDA Comparison

Compare ASPI & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ASP Isotopes Inc.

ASPI

ASP Isotopes Inc.

HOLD

Current Price

$4.04

Market Cap

475.3M

Sector

Industrials

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.16

Market Cap

460.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPI
KMDA
Founded
2021
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
475.3M
460.3M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
ASPI
KMDA
Price
$4.04
$7.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$12.00
$14.00
AVG Volume (30 Days)
4.0M
28.6K
Earning Date
04-10-2026
05-13-2026
Dividend Yield
N/A
3.08%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$23,849,000.00
N/A
Revenue This Year
$68.41
$13.94
Revenue Next Year
$126.69
$9.84
P/E Ratio
N/A
$24.59
Revenue Growth
475.48
N/A
52 Week Low
$3.51
$6.50
52 Week High
$14.49
$9.35

Technical Indicators

Market Signals
Indicator
ASPI
KMDA
Relative Strength Index (RSI) 38.29 48.84
Support Level $3.86 $6.97
Resistance Level $5.88 $7.33
Average True Range (ATR) 0.32 0.14
MACD 0.02 0.02
Stochastic Oscillator 30.40 63.10

Price Performance

Historical Comparison
ASPI
KMDA

About ASPI ASP Isotopes Inc.

ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: